Sagimet Biosciences SGMT
NASDAQ SGMT
$9.99 +0.25 (+2.57%)
At close: Oct 21, 2026 · 4:00 PM EDT

Sagimet Biosciences (SGMT) EBT Margin (2023)

Updated

Sagimet Biosciences' EBT Margin was -1394.00% in FY2023.

Analysis

Sagimet Biosciences (SGMT) EBT Margin (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 26.66%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 25.18%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 18.19%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 27.53%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -131.41%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -4.34%
10 Sagimet Biosciences 529.82 Mn -44.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -317.85%
API Access

Sagimet Biosciences EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=SGMT&period=max&api_key=YOUR_API_KEY